Jane Street’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16,200
Closed -$777K 10380
2024
Q1
$777K Buy
16,200
+10,500
+184% +$561K ﹤0.01% 5872
2023
Q4
$370K Buy
+5,700
New +$343K ﹤0.01% 7294
2023
Q2
Sell
-4,600
Closed -$284K 9760
2023
Q1
$284K Buy
+4,600
New +$276K ﹤0.01% 7293
2022
Q4
Sell
-25,700
Closed -$1.87M 10345
2022
Q3
$1.87M Buy
25,700
+15,800
+160% +$1.18M ﹤0.01% 4303
2022
Q2
$673K Sell
9,900
-15,800
-61% -$1.14M ﹤0.01% 6192
2022
Q1
$2.33M Buy
+25,700
New +$2.1M ﹤0.01% 4458
2021
Q4
Sell
-3,200
Closed -$260K 10950
2021
Q3
$260K Buy
3,200
+900
+39% +$75.6K ﹤0.01% 8445
2021
Q2
$215K Buy
+2,300
New +$223K ﹤0.01% 8702

Other funds holding NARI

Jane Street's NARI Position: Q1 2025 in Review

Jane Street sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 63,222 shares — an estimated $3.23M sold.

Jane Street first reported a position in NARI in Q3 2020 and held it in 16 quarters. The position peaked at $3.99M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Jane Street reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 63,222 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.23M.
  • Jane Street first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 16 quarters.
  • Jane Street's Inari Medical, Inc. Common Stock position peaked at $3.99M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.